BlackRock Finance, Inc. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 374 filers reported holding ROYALTY PHARMA PLC in Q2 2024. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2024$606,973,091
-5.8%
23,017,561
+8.5%
0.01%
-6.7%
Q1 2024$644,021,397
+6.8%
21,205,841
-1.2%
0.02%0.0%
Q4 2023$602,796,290
+8.0%
21,459,462
+4.4%
0.02%
-6.2%
Q3 2023$558,103,004
-12.5%
20,563,854
-0.9%
0.02%
-11.1%
Q2 2023$637,594,299
-10.8%
20,741,519
+4.5%
0.02%
-14.3%
Q1 2023$715,153,783
-6.8%
19,848,842
+2.2%
0.02%
-12.5%
Q4 2022$767,211,684
+4.5%
19,413,251
+6.3%
0.02%
-4.0%
Q3 2022$734,092,000
-5.1%
18,270,089
-0.7%
0.02%0.0%
Q2 2022$773,439,000
+13.5%
18,397,640
+5.2%
0.02%
+38.9%
Q1 2022$681,145,000
+2.3%
17,483,188
+4.6%
0.02%
+5.9%
Q4 2021$666,107,000
+19.2%
16,715,324
+8.1%
0.02%
+6.2%
Q3 2021$558,754,000
+32.5%
15,460,845
+50.3%
0.02%
+33.3%
Q2 2021$421,691,000
-29.3%
10,287,641
-24.7%
0.01%
-33.3%
Q1 2021$596,048,000
+31.5%
13,664,581
+50.9%
0.02%
+28.6%
Q4 2020$453,128,000
+188.6%
9,053,545
+142.6%
0.01%
+133.3%
Q3 2020$156,989,000
+57.7%
3,731,632
+82.0%
0.01%
+50.0%
Q2 2020$99,534,0002,050,1450.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2024
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$294,957,00088.74%
Vantage Consulting Group Inc 8,705,551$379,735,00076.23%
Memorial Sloan Kettering Cancer Center 2,680,644$116,930,00072.07%
HARVARD MANAGEMENT CO INC 10,714,284$467,357,00026.11%
ROBERT WOOD JOHNSON FOUNDATION 970,151$4,231,798,00021.59%
Brown University 381,759$16,652,00011.44%
Overbrook Management Corp 771,155$33,638,0007.48%
SpiderRock Advisors, LLC 778,800$34,236,0004.79%
Renaissance Capital LLC 452,948$19,758,0002.93%
Lagoda Investment Management, L.P. 104,835$4,573,0002.28%
View complete list of ROYALTY PHARMA PLC shareholders